Fueling the fire: Inflammatory forms of cell death and implications for cancer immunotherapy. Cancer Discov. 2021; 11: 266–281. doi: 10.1158/2159-8290
SR Rosenbaum , NA Wilski , AE Aplin
CD-20-0805.[Europe PMC free article][Abstract][CrossRef][Google Scholar]
8
Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy. Cancer Discov. 2021; 11: 266–81
SR Rosenbaum , NA Wilski , AE Aplin
3
Abstract A52: Extracellular matrix regulation of ErbB3 in a subset of wild-type BRAF/NRAS melanoma
Sheera Rosenbaum , Claudia Capparelli , Lisa D. Berman-Booty , Nadège Gaborit
Molecular Cancer Therapeutics 14
2015
ErbB3–ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas
Claudia Capparelli , Sheera Rosenbaum , Lisa D. Berman-Booty , Amel Salhi
Cancer Research 75 ( 17) 3554 -3567
14
2015
RAC1 P29S regulates PD-L1 expression in melanoma
Ha Linh Vu , Sheera Rosenbaum , Timothy J. Purwin , Michael A. Davies
Pigment Cell & Melanoma Research 28 ( 5) 590 -598
42
2015
Running INTERFERONce on immunotherapy.
Sheera Rosenbaum , Andrew Aplin
Pigment Cell & Melanoma Research 31 ( 3) 352 -353
2018
Fibroblast-derived neuregulin 1 promotes compensatory ErbB3 receptor signaling in mutant BRAF melanoma.
Claudia Capparelli , Sheera Rosenbaum , Adam C. Berger , Andrew E. Aplin
Journal of Biological Chemistry 290 ( 40) 24267 -24277
34
2015
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
Claudia Capparelli , Timothy J Purwin , McKenna Glasheen , Signe Caksa
Nature communications 13 ( 1) 1381
12
2022
The aged tumor microenvironment influences tolerance to targeted therapy via NR2F1 overexpression in BRAF-mutant melanoma
Manoela Tiago , Timothy J Purwin , Mitchell E Fane , Yash Chhabra
CANCER RESEARCH 83 ( 2)
2023
Abstract A005: The aged tumor microenvironment influences tolerance to targeted therapy via NR2F1 overexpression in BRAF-mutant melanoma
Manoela Tiago , Timothy J Purwin , Mitchell E Fane , Yash Chhabra
Cancer Research 83 ( 2_Supplement_1) A005 -A005
2023
Targeting SOX10-deficient cells to reduce resistance to targeted therapy in melanoma
Claudia Capparelli , Timothy J Purwin , Manoela Tiago , Nicole Wilski
Cancer Research 81 ( 13_Supplement) 40 -40
2021
MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRASáMelanoma
Ha Linh Vu , Sheera Rosenbaum , Claudia Capparelli , Timothy J Purwin
Journal of Investigative Dermatology 136 ( 2) 453 -463
16
2016
The Role of Lineage-specific Transcription Factors in Regulating Anti-tumor Immune Responses in Melanoma
Sheera Rosenbaum
Thomas Jefferson University
2021
Stromal neuregulin-1 promotes adaptive resistance in mutant BRAF melanoma
Claudia Capparelli , Sheera Rosenbaum , Adam Berger , Andrew E Aplin
Cancer Research 75 ( 15_Supplement) 2681 -2681
2015
Fibroblast-Derived Neuregulin-1 Promotes Compensatory ErbB3 Signaling in Mutant BRAF Melanoma
Claudia Capparelli , Sheera Rosenbaum , Adam C Berger , Andrew E Aplin
2015
Supplemental Figure Legends and Figures MIG6 is MEK-regulated and affects EGF-induced migration in mutant NRAS melanoma
Ha Linh Vu , Sheera Rosenbaum , Claudia Capparelli , Timothy J Purwin
Abstract A33: The next-generation BET inhibitor, PLX51107, delays melanoma growth, altering the tumor immune microenvironment via Cox2 inhibition
Inna Chervoneva , Andrew E. Aplin , Claudia Capparelli , Edward J. Hartsough
Cancer immunology research 8
2020
Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy.
Andrew E. Aplin , Sheera R. Rosenbaum , Nicole A. Wilski
Cancer Discovery 11 ( 2) 266 -281
1
2021
CADM1 is a TWIST1-regulated suppressor of invasion and survival.
Edward J. Hartsough , Michele B. Weiss , Shea A. Heilman , Timothy J. Purwin
Cell Death and Disease 10 ( 4) 281
26
2019
FOXD3 Regulates VISTA Expression in Melanoma
Sheera R. Rosenbaum , Meghan Knecht , Mehri Mollaee , Zhijiu Zhong
Cell Reports 30 ( 2) 510
40
2020